跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
RHENALAID - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
RHENALAID
Approved
STANDARD
RHENALAID
Northfield Laboratories, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
5d77fc6d3c62c426
Company
Northfield Laboratories, Inc.
Type
Standard
Approval Details
Approval Id
5d77fc6d3c62c426
Drug Approval Philippines Name
RHENALAID
Product Name
RHENALAID
Registration Number
HMR-162
Brand Name
RHENALAID
Generic Name
Blumea balsamifera L. (Sambong Leaf)
Dosage Form
Tablet
Dosage Strength
500 mg
Manufacturer
Northfield Laboratories, Inc.
Trader
Interhealthcare Pharmaceuticals. Inc.
Distributor
Savemore Pharmacy And Minimart, Inc.
Issuance Date
24 January 2025
Expiry Date
20 January 2030
Pharmacologic Category
Herbal Medicine (Anti-urolithiasis/Diuretic)
Classification
Household Remedy (HR)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
5d77fc6d3c62c426
Type
Standard
Back to Philippines FDA Approvals